Veterinary medicines European public assessment report (EPAR): Purevax RCPCh FeLV, vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Purevax RCPCh, Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Innovax-ND-ILT, Marek's disease vaccine, Newcastle disease vaccine & infectious laryngotracheitis vaccine (live recombinant), Status: Authorised

Clinical evaluation of therapeutic radiopharmaceuticals in oncology - Scientific guideline

Orphan designation: adenovirus associated viral vector serotype 5 containing the human pde6β gene Treatment of retinitis pigmentosa, 19/06/2013 Positive

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 October 2024

Summary of opinion: Eluracat Positive

Orphan designation: Allogeneic umbilical cord-derived mesenchymal stromal cells, pooled Treatment of perinatal asphyxia, 13/12/2023 Positive

Orphan designation: Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid Treatment of amyloid light-chain amyloidosis, 08/02/2013 Positive

Human medicines European public assessment report (EPAR): Xadago, safinamide, Date of authorisation: 23/02/2015, Revision: 15, Status: Authorised